Vitamin Shoppe (VSI) Shares Up 5.5%

Shares of Vitamin Shoppe, Inc (NYSE:VSI) shot up 5.5% during trading on Tuesday . The company traded as high as $3.90 and last traded at $3.85. 612,400 shares changed hands during trading, an increase of 18% from the average session volume of 520,268 shares. The stock had previously closed at $3.65.

A number of brokerages recently commented on VSI. Zacks Investment Research cut shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. Morgan Stanley set a $8.00 target price on shares of Vitamin Shoppe and gave the stock a “hold” rating in a research note on Thursday, August 10th. Goldman Sachs Group reiterated a “sell” rating and issued a $6.00 target price (down from $13.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. Deutsche Bank reiterated a “hold” rating and issued a $7.00 target price (down from $14.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. Finally, Barclays lowered their target price on shares of Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 10th. Four investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $5.00.

The company has a debt-to-equity ratio of 0.59, a current ratio of 2.07 and a quick ratio of 0.32. The company has a market cap of $91.11, a P/E ratio of 4.09 and a beta of 0.69.

Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.20). The firm had revenue of $288.20 million during the quarter, compared to analysts’ expectations of $297.61 million. Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The business’s revenue for the quarter was down 8.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.50 earnings per share. sell-side analysts forecast that Vitamin Shoppe, Inc will post 0.34 earnings per share for the current fiscal year.

Several institutional investors have recently bought and sold shares of VSI. Macquarie Group Ltd. purchased a new stake in shares of Vitamin Shoppe during the 3rd quarter valued at $101,000. BNP Paribas Arbitrage SA raised its position in shares of Vitamin Shoppe by 2.1% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its position in shares of Vitamin Shoppe by 18.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock valued at $110,000 after buying an additional 1,440 shares in the last quarter. Wolverine Trading LLC purchased a new stake in shares of Vitamin Shoppe during the 2nd quarter valued at $131,000. Finally, UBS Asset Management Americas Inc. raised its position in shares of Vitamin Shoppe by 17,041.4% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after buying an additional 11,929 shares in the last quarter. Hedge funds and other institutional investors own 89.78% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://www.chaffeybreeze.com/2017/12/07/vitamin-shoppe-vsi-shares-up-5-5.html.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply